附录3---附录6 略（请首页下载全文阅读） 七、参考文献1.Recommendations
for Standards Regarding Preclinical Neuroprotective
and Restorative Drug Development. Stroke，1999；30:2752-2758 2.Recommendations
for Clinical Trial Evaluation of Acute Stroke Therapies. Marc Fisher. Stroke，2001；32:1598-1606 3.Recommendations for Advancing Development of Acute Stroke Therapies：Stroke
Therapy Academic Industry Roundtable 3. Marc Fisher，Stroke. 2003；34:1539-1546 4.Enhancing the Development and Approval of Acute Stroke Therapies：Stroke Therapy
Academic Industry Roundtable. Marc Fisher，Stroke. 2005；36:1808-1813 5.Recommendations
From the STAIR V Meeting on Acute Stroke Trials，Technology and Outcomes. Marc Fisher，Stroke. 2007；38:245-248 6.Stroke
Therapy Academic Industry Roundtable （STAIR） Recommendations for Extended
Window Acute Stroke Therapy Trials. Jeffrey L. Saver，Stroke. 2009；40:2594-2600 7.Stroke
Treatment Academic Industry Roundtable （STAIR） Recommendations for Maximizing
the Use of Intravenous Thrombolytics and
Expanding Treatment Options With Intra-arterial and Neuroprotective
Therapies. Gregory W.
Albers， Stroke. 2011；42:2645-2650 8.Points to consider on clinical investigation of medicinal products for the treatment of acute stroke Stroke. CPMP/EWP/560/98，20 september 2001 9.Statistical Principles for Clinical Trials（ICH E9）， http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002928.pdf 10.Choice of Control Group and Related Issues in Clinical Trials（ICH E10）， http://www.ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2009/09/WC500002925.pdf 11.《中药新药治疗中风临床研究技术指导原则》， http://www.sfda.gov.cn/WS01/CL1616/134584.html |
